Annual Current Liabilities
$276.10 M
+$250.58 M+981.69%
December 31, 2023
Summary
- As of February 20, 2025, IRWD annual total current liabilities is $276.10 million, with the most recent change of +$250.58 million (+981.69%) on December 31, 2023.
- During the last 3 years, IRWD annual current liabilities has risen by +$243.93 million (+758.18%).
- IRWD annual current liabilities is now at all-time high.
Performance
IRWD Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$49.38 M
+$3.87 M+8.51%
September 30, 2024
Summary
- As of February 20, 2025, IRWD quarterly total current liabilities is $49.38 million, with the most recent change of +$3.87 million (+8.51%) on September 30, 2024.
- Over the past year, IRWD quarterly current liabilities has stayed the same.
- IRWD quarterly current liabilities is now -83.83% below its all-time high of $305.39 million, reached on June 30, 2023.
Performance
IRWD Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
IRWD Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +981.7% | 0.0% |
| 3 y3 years | +758.2% | -69.5% |
| 5 y5 years | +131.0% | -69.5% |
IRWD Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +981.7% | -83.8% | +112.0% |
| 5 y | 5-year | at high | +981.7% | -83.8% | +112.0% |
| alltime | all time | at high | +981.7% | -83.8% | +112.0% |
Ironwood Pharmaceuticals Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $49.38 M(+8.5%) |
| Jun 2024 | - | $45.51 M(-82.0%) |
| Mar 2024 | - | $252.44 M(-8.6%) |
| Dec 2023 | $276.10 M(+981.7%) | $276.10 M(-1.6%) |
| Sep 2023 | - | $280.58 M(-8.1%) |
| Jun 2023 | - | $305.39 M(+1180.8%) |
| Mar 2023 | - | $23.84 M(-6.6%) |
| Dec 2022 | $25.52 M(-84.2%) | $25.52 M(-5.9%) |
| Sep 2022 | - | $27.12 M(+16.4%) |
| Jun 2022 | - | $23.30 M(-84.2%) |
| Mar 2022 | - | $147.40 M(-8.8%) |
| Dec 2021 | $161.70 M(+402.6%) | $161.70 M(+11.0%) |
| Sep 2021 | - | $145.69 M(+8.4%) |
| Jun 2021 | - | $134.37 M(+469.3%) |
| Mar 2021 | - | $23.60 M(-26.6%) |
| Dec 2020 | $32.17 M(-21.4%) | $32.17 M(-2.2%) |
| Sep 2020 | - | $32.90 M(+23.2%) |
| Jun 2020 | - | $26.70 M(-3.3%) |
| Mar 2020 | - | $27.59 M(-32.6%) |
| Dec 2019 | $40.93 M(-65.8%) | $40.93 M(-22.5%) |
| Sep 2019 | - | $52.80 M(-52.4%) |
| Jun 2019 | - | $110.86 M(-6.5%) |
| Mar 2019 | - | $118.57 M(-0.8%) |
| Dec 2018 | $119.52 M(+81.0%) | $119.52 M(+6.2%) |
| Sep 2018 | - | $112.58 M(+18.5%) |
| Jun 2018 | - | $94.98 M(+52.4%) |
| Mar 2018 | - | $62.34 M(-5.6%) |
| Dec 2017 | $66.03 M(-27.5%) | $66.03 M(+2.4%) |
| Sep 2017 | - | $64.49 M(-19.4%) |
| Jun 2017 | - | $79.97 M(+1.4%) |
| Mar 2017 | - | $78.89 M(-13.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2016 | $91.13 M(+19.2%) | $91.13 M(-4.4%) |
| Sep 2016 | - | $95.31 M(+4.7%) |
| Jun 2016 | - | $91.00 M(+16.5%) |
| Mar 2016 | - | $78.11 M(+2.2%) |
| Dec 2015 | $76.47 M(+26.3%) | $76.47 M(+12.8%) |
| Sep 2015 | - | $67.78 M(+9.1%) |
| Jun 2015 | - | $62.10 M(+3.8%) |
| Mar 2015 | - | $59.81 M(-1.2%) |
| Dec 2014 | $60.54 M(+47.5%) | $60.54 M(+12.0%) |
| Sep 2014 | - | $54.06 M(+29.9%) |
| Jun 2014 | - | $41.63 M(+8.1%) |
| Mar 2014 | - | $38.50 M(-6.2%) |
| Dec 2013 | $41.04 M(-25.3%) | $41.04 M(+3.4%) |
| Sep 2013 | - | $39.70 M(-9.7%) |
| Jun 2013 | - | $43.97 M(-29.9%) |
| Mar 2013 | - | $62.68 M(+14.1%) |
| Dec 2012 | $54.94 M(-15.7%) | $54.94 M(+54.4%) |
| Sep 2012 | - | $35.58 M(-27.6%) |
| Jun 2012 | - | $49.12 M(-6.0%) |
| Mar 2012 | - | $52.28 M(-19.7%) |
| Dec 2011 | $65.13 M(+1.1%) | $65.13 M(-8.1%) |
| Sep 2011 | - | $70.85 M(+0.0%) |
| Jun 2011 | - | $70.84 M(+17.0%) |
| Mar 2011 | - | $60.53 M(-6.0%) |
| Dec 2010 | $64.43 M(+14.2%) | $64.43 M(+12.6%) |
| Jun 2010 | - | $57.20 M(+4.0%) |
| Mar 2010 | - | $54.98 M(-2.6%) |
| Dec 2009 | $56.44 M(+53.4%) | $56.44 M(+10.4%) |
| Sep 2009 | - | $51.14 M(+39.0%) |
| Dec 2008 | $36.80 M(+22.9%) | $36.80 M |
| Dec 2007 | $29.93 M | - |
FAQ
- What is Ironwood Pharmaceuticals annual total current liabilities?
- What is the all time high annual current liabilities for Ironwood Pharmaceuticals?
- What is Ironwood Pharmaceuticals annual current liabilities year-on-year change?
- What is Ironwood Pharmaceuticals quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Ironwood Pharmaceuticals?
- What is Ironwood Pharmaceuticals quarterly current liabilities year-on-year change?
What is Ironwood Pharmaceuticals annual total current liabilities?
The current annual current liabilities of IRWD is $276.10 M
What is the all time high annual current liabilities for Ironwood Pharmaceuticals?
Ironwood Pharmaceuticals all-time high annual total current liabilities is $276.10 M
What is Ironwood Pharmaceuticals annual current liabilities year-on-year change?
Over the past year, IRWD annual total current liabilities has changed by +$250.58 M (+981.69%)
What is Ironwood Pharmaceuticals quarterly total current liabilities?
The current quarterly current liabilities of IRWD is $49.38 M
What is the all time high quarterly current liabilities for Ironwood Pharmaceuticals?
Ironwood Pharmaceuticals all-time high quarterly total current liabilities is $305.39 M
What is Ironwood Pharmaceuticals quarterly current liabilities year-on-year change?
Over the past year, IRWD quarterly total current liabilities has changed by $0.00 (0.00%)